NP0333527 | strigaibol G | | | C88H153N21O23
1873.3160 Da 1872.14482 Da | 1H NMR Spectrum (1D, 850 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 214 MHz, C5D5N, experimental) |
|
NP0333528 | strigaibol H | | | C88H153N21O24
1889.3150 Da 1888.13973 Da | 1H NMR Spectrum (1D, 850 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 1H] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | [1H, 13C] NMR Spectrum (2D, 850 MHz, C5D5N, experimental) | 13C NMR Spectrum (1D, 214 MHz, C5D5N, experimental) |
|
NP0333530 | penicimenolide G | | | C16H22O4
278.3480 Da 278.15181 Da | |
NP0333535 | (S)-cis-Verbenol | | | C10H16O
152.2370 Da 152.12012 Da | 1H NMR Spectrum (1D, 600.133705802, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333562 | 24-hydroxymuristerone A | | | C27H44O9
512.6400 Da 512.29853 Da | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0333563 | 24-hydroxykaladasterone | | | C27H42O8
494.6250 Da 494.28797 Da | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
NP0333565 | 2,2′,7,7′-tetramethoxy-[1,1′-biphenanthrene]-4,4′,6,6′-tetraol | | | C32H26O8
538.5520 Da 538.16277 Da | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0333567 | 2-Methoxy-2-methylpropanoic acid | | | C5H10O3
118.1320 Da 118.06299 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333568 | 2-Methyl-4-phenyl-2-butanol | | | C11H16O
164.2441 Da 164.12012 Da | 1H NMR Spectrum (1D, 600.133705802, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333569 | 2-Phenyl-1-propanol | | | C9H12O
136.1940 Da 136.08882 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333570 | 3-Methoxypropanoic acid | | | C4H8O3
104.1050 Da 104.04734 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0333581 | Subphenazine A | | | C19H18N2O5
354.3620 Da 354.12157 Da | 1H NMR Spectrum (1D, 500.23308892 MHz, CDCl3, predicted) | 1H NMR Spectrum (1D, 500.23308892 MHz, CD3OD, predicted) | 13C NMR Spectrum (1D, 125.79551184 MHz, CD3OD, predicted) | 1H NMR Spectrum (1D, 500.23308892 MHz, CD3OD, predicted) |
|
NP0333582 | alternaria G | | | C24H26O7
426.4650 Da 426.16785 Da | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0333583 | alternaria H | | | C24H26O7
426.4650 Da 426.16785 Da | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0333600 | triantaspirol A | | | C30H24O9
528.5130 Da 528.14203 Da | 1H NMR Spectrum (1D, 500 MHz, C6D6, experimental) | 1H NMR Spectrum (1D, 500 MHz, C6D6, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) |
|
NP0333601 | triantaspirol B | | | C30H24O8
512.5140 Da 512.14712 Da | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0333602 | triantaspirol C | | | C30H24O8
512.5140 Da 512.14712 Da | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0333603 | paraphaeolactone C1 | | | C17H16O6
316.3090 Da 316.09469 Da | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0333604 | paraphaeolactone C2 | | | C17H16O6
316.3090 Da 316.09469 Da | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) |
|
NP0333605 | triantaspirol B triacetate | | | C36H30O11
638.6250 Da 638.17881 Da | |
NP0333606 | triantaspirol C triacetate | | | C36H30O11
638.6250 Da 638.17881 Da | |
NP0333607 | CJ-12,372 triacetate | | | C26H22O8
462.4540 Da 462.13147 Da | |
NP0333621 | 2-Aminobenzamide-actiphenol | | | C22H23N3O5
409.4420 Da 409.16377 Da | |
NP0333622 | Salamandamide A | | | C21H39N3O6
429.5580 Da 429.28389 Da | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 400 MHz, C2D6OS, experimental) | [1H, 15N] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 15N] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) |
|
NP0333669 | Cicholosumin A | | | C20H26O6
362.4220 Da 362.17294 Da | 1H NMR Spectrum (1D, 599.80599754, C2D6OS, simulated) | 1H NMR Spectrum (1D, 600.23370642, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) |
|